Covid-19: relaxed EU regulatory requirements
The coronavirus has had an enormous impact on European regulatory activity. To ease the strain and maintain vital supplies, the European Commission, European Medicines Agency, and Heads of Medicines Agencies published updated guidance in April, including new flexibility and simplified and accelerated authorisation procedures.